Ulrich Wandschneider
Person
MEDICLIN Aktiengesellschaft
Japan
Biography
Dr. Ulrich Wandschneider has been Chairman of the Supervisory Board at MEDICLIN Aktiengesellschaft since June 1, 2012. He is Chairman of the General and Personnel Committee, the Meditation Committee and the Nomination Committee at the Company. Before that, he acted as Member of the Management Board at MEDICLIN AG from November 11, 2011. Previously he acted as Chairman of the Management Board and Chief Executive Officer of the Company from November 1, 2004. He was responsible for strategy and product development, operative clinics management, marketing/sales, contract management, public relations/investor relations, personnel and for quality/risk management at the Company. Prior to joining the Company, he was Partner in an international consulting firm. He has been Chairman of the Supervisory Board of Asklepios Kliniken Gesellschaft mbH and Member of the Supervisory Board of Vanguard AG, among others.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology
